NORTHERN TRUST CORP - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 114 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$5,088,000
-16.3%
96,310
-2.9%
0.00%0.0%
Q2 2020$6,082,000
+6.0%
99,228
-2.2%
0.00%
-50.0%
Q1 2020$5,737,000
+1.5%
101,419
+2.2%
0.00%
+100.0%
Q4 2019$5,650,000
+1.7%
99,231
-4.4%
0.00%0.0%
Q3 2019$5,553,000
-1.3%
103,772
+10.2%
0.00%0.0%
Q2 2019$5,625,000
-2.9%
94,209
+1.4%
0.00%0.0%
Q1 2019$5,792,000
+3.3%
92,931
+0.4%
0.00%
-50.0%
Q4 2018$5,608,000
+1.5%
92,543
-2.0%
0.00%
+100.0%
Q3 2018$5,523,000
+34.6%
94,437
+3.3%
0.00%0.0%
Q2 2018$4,102,000
+4.1%
91,422
+2.9%
0.00%0.0%
Q1 2018$3,940,000
+3.5%
88,856
+1.1%
0.00%0.0%
Q4 2017$3,807,000
-4.9%
87,857
+2.0%
0.00%0.0%
Q3 2017$4,005,000
-4.3%
86,094
+1.8%
0.00%0.0%
Q2 2017$4,185,000
-4.8%
84,533
+5.4%
0.00%0.0%
Q1 2017$4,394,000
-2.8%
80,182
-1.2%
0.00%0.0%
Q4 2016$4,519,000
+23.9%
81,131
+1.6%
0.00%0.0%
Q3 2016$3,646,000
+16.8%
79,835
+2.1%
0.00%0.0%
Q2 2016$3,122,000
+18.3%
78,169
+3.2%
0.00%0.0%
Q1 2016$2,639,000
-15.0%
75,774
+4.8%
0.00%0.0%
Q4 2015$3,106,000
+0.1%
72,285
+1.4%
0.00%0.0%
Q3 2015$3,102,000
-2.8%
71,253
+15.2%
0.00%0.0%
Q2 2015$3,191,000
+32.5%
61,841
+0.5%
0.00%0.0%
Q1 2015$2,408,000
-0.2%
61,506
-1.6%
0.00%0.0%
Q4 2014$2,413,000
+15.5%
62,498
+5.6%
0.00%0.0%
Q3 2014$2,090,000
+146.5%
59,195
+88.2%
0.00%
Q2 2014$848,000
+17.9%
31,445
+13.4%
0.00%
Q1 2014$719,000
+27.3%
27,723
+6.4%
0.00%
Q4 2013$565,000
+18.7%
26,047
+6.6%
0.00%
Q3 2013$476,000
-55.2%
24,439
-64.1%
0.00%
Q2 2013$1,062,00068,0520.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q3 2020
NameSharesValueWeighting ↓
UBS ASSET MANAGEMENT AMERICAS INC 2,300$203,550,0000.00%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders